Mice Model Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Mice Model Market is Segmented by Type (Inbred Mice, Outbred Mice, Genetically Engineered Mice, Hybrid Mice, Surgically Modified Mice, and Spontaneous Mutant Mice), Service (Breeding, Cryopreservation, Model In-Licensing, Genetic Testing, and Other Services), Technology (CRISPR/CAS9, Embryonic Stem Cell Injection, Nuclear Transfer, and Other Technologies), Application (Oncology, Cardiovascular Studies, Neurology, and Other Applications), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The Market Provides the Value (in USD Million) for the Above-Mentioned Segments.

Mice Model Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Mice Model Market Size

Mice Model
Study Period 2019 - 2030
Base Year For Estimation 2024
Market Size (2025) USD 1.60 Billion
Market Size (2030) USD 2.23 Billion
CAGR (2025 - 2030) 6.80 %
Fastest Growing Market Asia Pacific
Largest Market North America

Major Players

Mice Model Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Mice Model Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Mice Model Market Analysis

The Mice Model Market size is estimated at USD 1.60 billion in 2025, and is expected to reach USD 2.23 billion by 2030, at a CAGR of 6.8% during the forecast period (2025-2030).

The COVID-19 pandemic had a significant impact on the market studied. Research laboratories and biopharmaceutical industries extensively used mice models in preclinical development. For instance, according to an article published by Methods of Molecular Biology in October 2022, a small rodent animal model using K18 hACE2 transgenic mice was presented as an option for understanding the pathogenicity of natural SARS-CoV-2 strains. Thus, the adoption of mouse models to analyze the progress made since the discovery of SARS-CoV-2 in developing and applying relevant mouse models had been anticipated to drive market growth during the pandemic. However, as the COVID-19 cases started to decline, the market had begun to show average pre-pandemic level growth and was likely to continue its significant growth rate during the forecast period.

Factors such as increasing innovations in mice models, rising demand for personalized medicine, and a growing pipeline of pharmaceutical and biopharmaceutical companies are driving the growth of the mice model market. For instance, an article published by Molecular Neurodegeneration in June 2022 stated that the genetic engineering of novel mouse models using knock-in approaches addresses some of the limitations of genetic mutations. Also, the article mentioned in its conclusion that the scientific community should use the open-access mouse model as a resource to study disease-relevant biology. Thus, such instances are anticipated to boost the demand for mice models, further driving the market growth.

In addition, the rising demand for precision medicine is driving the growth. For instance, in April 2022, an article published in the journal Nature Medicine reported that the increasing use of genomic profiling for diagnosis and therapy guidance in many tumor types had increased the use of precision medicine in cancer patients. With the increased demand for precision medicine, the utilization of mouse models will also increase, leading to market growth.

Furthermore, several key market players have also been investing in the market's growth. For instance, in January 2022, Inotiv acquired Orient BioResource Center, Inc. from Orient Bio, Inc., a preclinical CRO and animal model supplier based in Seongnam, South Korea. Orient BioResource Center is a primate quarantine & holding facility located near Alice, Texas.

Hence, as per the abovementioned factors, the mice model market is anticipated to grow over the forecast period. However, alternatives to animal testing and regulations for the ethical use of animals are expected to restrain the market's growth.

Mice Model Industry Overview

The mice model market is moderately concentrated in nature due to the presence of companies operating globally as well as regionally. The competitive landscape includes an analysis of a few international as well as local companies that hold market shares and are well known, including Allentown LLC, Charles River Laboratories International Inc., ENVIGO, Genoway, Harbour Biomed, and The Jackson Laboratory, among others.

Mice Model Market Leaders

  1. genOway

  2. Charles River

  3. Taconic Biosciences Inc.

  4. Envigo

  5. The Jackson Laboratory

  6. *Disclaimer: Major Players sorted in no particular order
Mice Model Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Mice Model Market News

  • February 2024: University of Texas Southwestern Medical Center introduced a new compound that significantly extended survival in a mouse model of amyotrophic lateral sclerosis (ALS) by blocking the activity of a group of proteins called MAP4Ks.
  • November 2023: Scientists at the UCI MODEL-AD group developed a new mouse model that could help us understand Alzheimer’s disease better. The mouse model is called Trem2R47H NSS, and it has a genetic variant called TREM2 R47H that is one of the strongest known risk factors for developing late-onset Alzheimer’s in humans

Mice Model Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Innovation in Mice Models
    • 4.2.2 Rising Demand for Personalized Medicine
    • 4.2.3 Growing Pipeline of Pharmaceutical and Biophamraceutical Companies
  • 4.3 Market Restraints
    • 4.3.1 Alternatives to Animal Testing
    • 4.3.2 Regulations for the Ethical Use of Animals
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Type
    • 5.1.1 Inbred Mice
    • 5.1.2 Outbred Mice
    • 5.1.3 Genetically Engineered Mice
    • 5.1.4 Hybrid/Congenic Mice
    • 5.1.5 Other Types
  • 5.2 By Service
    • 5.2.1 Breeding
    • 5.2.2 Cryopreservation
    • 5.2.3 Model in-Licensing
    • 5.2.4 Genetic Testing
    • 5.2.5 Other Services
  • 5.3 By Technology
    • 5.3.1 CRISPR/CAS9
    • 5.3.2 Embryonic Stem Cell Injection
    • 5.3.3 Nuclear Transfer
    • 5.3.4 Other Technologies
  • 5.4 By Application
    • 5.4.1 Oncology
    • 5.4.2 Cardiovascular Studies
    • 5.4.3 Neurology
    • 5.4.4 Other Applications
  • 5.5 Geography
    • 5.5.1 North America
    • 5.5.1.1 United States
    • 5.5.1.2 Canada
    • 5.5.1.3 Mexico
    • 5.5.2 Europe
    • 5.5.2.1 Germany
    • 5.5.2.2 United Kingdom
    • 5.5.2.3 France
    • 5.5.2.4 Italy
    • 5.5.2.5 Spain
    • 5.5.2.6 Rest of Europe
    • 5.5.3 Asia-Pacific
    • 5.5.3.1 China
    • 5.5.3.2 Japan
    • 5.5.3.3 India
    • 5.5.3.4 Australia
    • 5.5.3.5 South Korea
    • 5.5.3.6 Rest of Asia-Pacific
    • 5.5.4 Middle East and Africa
    • 5.5.4.1 GCC
    • 5.5.4.2 South Africa
    • 5.5.4.3 Rest of Middle East and Africa
    • 5.5.5 South America
    • 5.5.5.1 Brazil
    • 5.5.5.2 Argentina
    • 5.5.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Allentown LLC
    • 6.1.2 Charles River Laboratories International Inc.
    • 6.1.3 ENVIGO
    • 6.1.4 Genoway
    • 6.1.5 Harbour Biomed
    • 6.1.6 Horizon Discovery Group PLC (Sage Labs Inc.)
    • 6.1.7 Ingenious Targeting Laboratory
    • 6.1.8 Janvier Labs
    • 6.1.9 Ozgene Pty Ltd
    • 6.1.10 PolyGene
    • 6.1.11 Taconic Biosciences Inc.
    • 6.1.12 The Andersons Inc.
    • 6.1.13 The Jackson Laboratory
    • 6.1.14 Trans Genic Inc.
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Mice Model Industry Segmentation

Mice models are biological representations of human diseases or syndromes. Mice and humans have approximately 99% similarity in their DNA. By studying mice that have symptoms of diseases like Alzheimer's, diabetes, or cancer, we can learn a lot more about how these diseases might be treated in patients.

The mice model market is segmented by type (inbred mice, outbred mice, genetically engineered mice, hybrid mice, surgically modified mice, and spontaneous mutant mice), service (breeding, cryopreservation, model in-licensing, genetic testing, and other services), technology (CRISPR/CAS9, embryonic stem cell injection, nuclear transfer, and other technologies), application (oncology, cardiovascular studies, neurology, and other applications), and geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally.

The report offers the value (in USD) for the above segments.

By Type Inbred Mice
Outbred Mice
Genetically Engineered Mice
Hybrid/Congenic Mice
Other Types
By Service Breeding
Cryopreservation
Model in-Licensing
Genetic Testing
Other Services
By Technology CRISPR/CAS9
Embryonic Stem Cell Injection
Nuclear Transfer
Other Technologies
By Application Oncology
Cardiovascular Studies
Neurology
Other Applications
Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Mice Model Market Research Faqs

How big is the Mice Model Market?

The Mice Model Market size is expected to reach USD 1.60 billion in 2025 and grow at a CAGR of 6.80% to reach USD 2.23 billion by 2030.

What is the current Mice Model Market size?

In 2025, the Mice Model Market size is expected to reach USD 1.60 billion.

Who are the key players in Mice Model Market?

genOway, Charles River, Taconic Biosciences Inc., Envigo and The Jackson Laboratory are the major companies operating in the Mice Model Market.

Which is the fastest growing region in Mice Model Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Mice Model Market?

In 2025, the North America accounts for the largest market share in Mice Model Market.

What years does this Mice Model Market cover, and what was the market size in 2024?

In 2024, the Mice Model Market size was estimated at USD 1.49 billion. The report covers the Mice Model Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Mice Model Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Mice Model Industry Report

Statistics for the 2025 Mice Model market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Mice Model analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.